Clinical Trial Update: Extended-release Guanfacine Hydrochloride in Children/Adolescents With Attention-deficit/Hyperactivity [Phase 3]

View source ↗

Summary

Phase 3 trial update for extended-release guanfacine hydrochloride in children and adolescents with attention deficit disorder has completed recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Disorder

Drugs mentioned

• extended-release guanfacine hydrochloride (guanfacine hydrochloride)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Attention Deficit Disorder | Phase 3 | Status: COMPLETED